Science & Innovation to create something better for world's smokers
Our 35,000 employees worldwide are united by one goal: to create something better for the world's smokers. Our exciting work in the field of science and innovation is transforming our portfolio of next generation high quality products.
As we continue to improve our traditional tobacco products to always offer the best quality and taste to our consumers, we are witnessing the biggest consumer shift in our history, with millions of smokers around the world switching to potentially less harmful alternatives to tobacco.
We want smokers to choose products with lower health risks and encourage them to make that change by offering a portfolio of high-quality NGP products, all based on leading science.
In 2013, we acquired the global patent portfolio for vapour technologies from the original inventor of the e-cigarette Hon Lik. Mr. Hon Lik joined our company as head of our research and development team in China - a position he continues to hold to this day.
The cornerstone of our NGP portfolio is the groundbreaking vapour brand, Myblu.
NGP technology is evolving rapidly and we have significantly expanded our scientific and technical capabilities in 2017 with the acquisition of the research and innovation company Nerudia. Nerudia focuses on developing a pipeline of innovations that goes beyond vapour.
We continue to strengthen our multi-category approach by expanding our presence in heated tobacco and modern oral nicotine.
We set high standards and want to make a significant contribution to the growing research in vaping and other products. This includes assessing their safety and demonstrating their potential to reduce the risk of smoking-related diseases. We comply with the ever-changing regulations in the markets in which we operate to enable the development of new and potentially less harmful products.
To stay up to date with NGP's developments, please see the news section on this page or follow us on Twitter @ImperialBrands